Access Full Report at https://databridgemarketresearch.com/reports/global-breast-reconstruction-market
Global breast reconstruction market is a highly concentrated market which includes key players and local players. The market has witnessed various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to rising prevalence & incidence of breast cancer and growing awareness about reconstructive breast surgeries. Emerging markets an offer and growth opportunity which is also posing as an opportunity for the market.
The market has witness developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of innovative technology. In July 2017, Sientra, Inc announced that they acquire Miramar Labs, Inc.(U.S), this acquisition will widen the aesthetics portfolio related to the breast reconstruction market.
Johnson & Johnson Services, Inc. dominated the global breast reconstruction market and accounts for the highest market share in 2018 which is followed by Allergan and Sientra Inc. The other key players in the market are GC Aesthetics PLC, Arion Laboratories., Cereplas, Shanghai Kangning Medical Device Co. Ltd., Implantech Associates Inc, , G&G Biotechnology Ltd, Polytech Health & Aesthetics GMBH, Hansbiomed Co. Ltd, Ideal Implant Incorporated, Guangzhou Wanhe Plastic Materials Co., Ltd., Establishment Labs S.A, Groupe Sebbin SAS,RTI Surgical, Inc, AirXpanders, Inc, PMT Corporation and others.
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. headquartered in New Jersey, U.S. was founded in 1886. The company focuses on in the research and development, manufacturing and sale of a wide range of products in the health care field. The company has three business segments that are pharmaceutical, medical devices and consumer. Market focused segment is medical devices; the revenue of medical devices is increased by 1.5% from 2017 to 2018. The company’s revenue is USD 81,581.00 Million in 2018. The company total employees are 1,35,000 as of December 2018.
The company has global presence in Europe, Western Hemisphere, Asia-Pacific, Africa, U.S. The company has various subsidiaries such as Janssen Global Services, LLC (Belgium), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), Janssen Global Services, LLC (Belgium) among others.
Allergan:
Allergan, headquartered in Dublin, Ireland was founded in 1983. The company focuses on manufacturing, developing and commercializing branded device, biologic, pharmaceutical, surgical and regenerative medicine products for patients. The company has four business segments that are US specialized therapeutics, US general medicine, international, other. Market focused segment is US specialized therapeutics; the revenue of US specialized therapeutics is increased by 1.72% from 2017 to 2018. The company total employees 16,900 as of December 2018. The company’s revenue is USD 15,747.90 Million in 2018.
The company has global presence in North America, South America, Europe, Asia, Middle East and Africa. The company has various subsidiaries such as ZELTIQ Aesthetics, Inc. (U.S.), Bonti, Inc. (U.S.), Allergan Medical (U.S.), Kythera Biopharmaceuticals, Inc. (U.S.), Oculeve, Inc. (U.S.) among others.
Sientra Inc:
Sientra Inc, headquartered in California, U.S. was founded in 2003. The company focus on providing true artists with the best tools which give optimal results, their best of breast products are exclusive to most skilled plastic surgeons. The company has two business segments that are breast Products, Miradry. Market focused segment is breast Products; the revenue of breast Products is increased by 17.46% from 2017 to 2018. The company total employees 259 as of December 2018. The company’s revenue is USD 68.13 Million in 2018.
The company has global presence in North America, Europe, Asia-Pacific, South America, Middle East and Africa.. The company has various subsidiaries such as Desert Acquisition Corporation (U.S.), miraDry Holdings (U.S.), Inc, Silimed, Inc. (U.S.), Miramar Labs Inc. (U.S.) and other.
